Pricing Log in Create free account

SeaStar Medical Holding Corporation (ICU) vs Moleculin Biotech, Inc. (MBRX)

SeaStar Medical Holding Corporation and Moleculin Biotech, Inc. are both Biotechnology companies. SeaStar Medical Holding Corporation is the larger, with a market value of $10.2M against $9.2M — 1.1× the size. SeaStar Medical Holding Corporation has negative trailing earnings, so its P/E is not meaningful; Moleculin Biotech, Inc. trades at 0.0×. Moleculin Biotech, Inc. has the higher net margin (0.00% vs −795.5%) and the lower return on invested capital (−417.3% vs 0.00%). Across the 13 metrics below, Moleculin Biotech, Inc. leads on 7 and SeaStar Medical Holding Corporation on 6.

Valuation

Metric ICU MBRX Biotechnology median
P/E n/m 0.04 10.26
P/S 4.53 n/m 9.18
P/B 1.81 0.21 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m 0.16 0.65
EV/Sales 1.96 n/m 8.98
Earnings yield (205.79%) 2,573.95% (34.89%)
Free cash flow yield (176.47%) (1,027.71%) (24.52%)

Profitability

Metric ICU MBRX Biotechnology median
Gross margin 92.64% 0.00% 65.16%
Operating margin (816.75%) 0.00% 0.00%
Net margin (795.50%) 0.00% 0.00%
Free cash flow margin (799.36%) 0.00% 0.00%
Return on equity (356.87%) (1,471.05%) (50.12%)
Return on assets (160.02%) (152.41%) (45.60%)
Return on invested capital 0.00% (417.27%) 0.00%

Growth

Metric ICU MBRX Biotechnology median
Revenue growth (TTM) 123.63% — 6.26%
EPS growth (last fiscal year) 91.16% 82.01% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ICU MBRX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.89 0.94 4.89
Net debt to EBITDA 0.99 0.35 1.01

Dividend

Metric ICU MBRX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ICU MBRX Biotechnology median
Market cap 10.20m 9.16m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack